David Lazar acquires Cyclacel Pharmaceuticals preferred stock, becomes interim CEO; stock jumps
Cyclacel Pharmaceuticals announces securities purchase agreement with investor David Lazar, new CEO appointed, and stock up ...
Cyclacel announces agreement for acquisition of preferred stock
Cyclacel Pharmaceuticals (CYCC) announced that the Company entered into a securities purchase agreement with investor David Lazar, pursuant to ...
Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing
Cyclacel Pharmaceuticals shares are trading higher by 77% during Friday's session. The company announced a securities purchase agreement with investor David Lazar.
Ault & Company, Inc. Announces Abandonment of Dutch Tender Offer to Acquire Shares of Common Stock of Hyperscale Data, Inc.
Ault & Company, Inc. (“Ault & Company”), today announced its abandonment of its planned cash tender offer to purchase up to ...
MicroStrategy eyes more Bitcoin with potential $2B preferred stock offering
MicroStrategy, the largest corporate holder of Bitcoin, is eyeing a $2 billion raise from a perpetual preferred stock ...
MicroStrategy to target capital raise of up to $2B in preferred stock
MicroStrategy (MSTR), in furtherance of its previously announced 21/21 Plan, a capital plan to raise $21 billion of equity and $21 billion of ...
Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell ...
New Preferred Stock IPOs, December 2024
Read here for an update on new investment opportunities in preferred stock and exchange traded debt offerings with yields ...
Nasdaq3d
EPR Properties's 9.00% Series E Cumulative Convertible Preferred Shares Goes Ex-Dividend Soon
On 12/31/24, EPR Properties's 9.00% Series E Cumulative Convertible Preferred Shares ... average yield of 7.89% in the "Real Estate" preferred stock category, according to Preferred Stock Channel.